Introduction
TB is a major public health problem worldwide. It is necessary for treatment of tuberculosis to be successful. Anti-tuberculosis drugs should be taken for a minimum period of six months for non-resistant pulmonary tuberculosis or sometimes 12 to 24 months in the case of extra-pulmonary and resistant tuberculosis [1] . Patients with retreatment tuberculosis (TB) represent those who have been treated previously for more than one month with anti-TB drugs and who have been diagnosed again with the disease. These patients mainly include relapses, treatment after failure, or loss to follow-up on a first-line treatment regimen [2] .
The detection and management of re-treatment TB cases have remained a challenge for the national TB control programs worldwide [3] [4] . World Health Organization (WHO) globally estimated that 3.5% of new TB cases and 18% of previously treated cases had MDR/RR-TB (Multidrug-resistant tuberculosis; Rifampicin resistance), and also 10.0 million people developed TB disease in 2017 I in which 5.8 million were men, 3.2 million were women, and 1.0 million were children. In Pakistan, New and relapse cases registered in 2016 were 356,390 with success rate 94%, while previously treated cases, excluding relapse, registered in 2016 was 9671 with success rate 78% while MDR/RR-TB cases started on second-line treatment in 2015 were 2544 and XDR-TB (Extreme Drug Resistance tuberculosis) cases started on second-line treatment in 2015 were 77 with a success rate of 64% and 29% respectively [4] [5] . In Pakistan, treatment success rate in smear-positive pulmonary TB is 88% [6] [7] [8] . Historically, patients treated with 4 drugs combination have success rate and the chances of recurrence are very low i.e., 2% -3%. Pakistan ranks 5th among 22 high TB burden countries and 4th among MDR-TB countries. Countrywide representative Drug Resistance Survey (DRS) was conducted in 2012 and the results showed that the estimated percentage of TB cases with DR-TB was 4.2% and 19.8% among New and Re-treatment cases respectively. While in 2016, there were 4.2% and 16% DR-TB cases in new and re-treatment cases making the annual burden of 14,000 new cases [9] .
This retrospective study aimed to assess the notification rate of re-treatment TB cases among all enrolled TB patients and comparison of retreatment TB cases in public and private sector under provincial TB control program in district Swat in Khyber Pakhtunkhwa from 2015-2017.
Methodology

Study Design and Study Population
This is a retrospective cohort study based on a review of the collected data from TB registers. Retreatment tuberculosis (TB) represents those who have been treated previously these patients include relapses, treatment after failure, or loss to follow-upon a first-line treatment regimen. 
Data Collection
The data was extracted through TB registers and TB treatment cards, Xpert MTB/RIF assay, culture and from a laboratory. For comparison-aggregated data of new pulmonary bacteriologically confirmed tuberculosis (NPBCT) patients were collected from the annual report.
Statistical Analysis
The aggregative data was extracted from the TB case notification register and treatment registers. Data were double entered in EPI data software version 3.1
and analyzed in SPSS version 16 and descriptive statistics were done to assess the characteristic of TB cases in Pakistan.
Ethical Approval
Permission to use the data and a local ethics exemption was obtained from the provincial TB control program, Khyber-Pakhtunkhwa. Since the study involved a review of records with no patient interaction, the informed consent was not required.
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Results
At district Swat between January 2015 to December 2017, 8663 TB cases were registered as shown in 
Discussions
This retrospective study was designed and done in DTC swat to determine the notification of re-treatment TB cases. In the current study, all the 123 retreatment TB patients record were reviewed and this is 1. More retreatment cases were reported from public health care facilities as compared to private. This may be for the reason that fewer public health facilities are registered and health care providers at private level are less interested to provide TB care, and this could be another reason. As routine approaches are no longer adequate to combat with the vast, fragmented and largely unregulated non-NTP sectors in many countries. In some developing countries, more than half of patients prefer to seek private medical care. However, the private sector has often failed to provide high-quality TB care, which NTPs are well positioned to deliver [10] . Out of 10.4 million tuberculosis (TB) patients in 2015, 4.3 million were either not diagnosed or not notified to national TB programmes (NTP) [11] . This means that a staggering 40% of the TB patients globally are invisible to the public health system [12] . As private sector accounts for a considerable proportion of health care delivered in the country, it means that there are enormous gaps present in the system and it is a major threat to global TB control. In swat region, retreatment failure rates are lower than the cure rate which is almost 100%.
Moreover, 101 (82.11%) relapse, treatment after loss to follow up 2 (1.62%) and treatment after failure 20 (16.26%) were classified as retreatment TB. This suggests that individuals who have been successfully treated for TB are at an increased risk of developing TB again. Knowing about the profile of retreatment patients and the related outcomes of treatment is important to implement a "patient-centered care" approach which is based on a thorough understanding of the patients being served.
Findings of our study have shown that there was increased recurrence in male patients who are over 20 years old. However, it is concerning that adults over 40 years who are supposed to be responsible and thus more capable of understanding the importance of treatment, appear to be the ones who defaulted more [13] . The finding of our study suggests that retreatment is indeed a common phenomenon that should be given due attention. Another study [14] found that the rate of recurrence TB was 18% in the study population with recurrence occurring after successful treatment and after default. The re-infection rate after successful treatment was estimated at 2.2/100-persons/year. People with previous TB have a four times higher risk of TB compared to TB new patients.
Consistent finding on the effect of gender and default from TB treatment, most studies had shown that males are more likely to default TB treatment than females. This may partly explain the relatively large proportion of males with retreatment TB in this study. The finding of this study with regards to males is similar to others that have been reported from studies in Turkey, Nigeria, and India. In Turkey [14] , the risk factors for non-successful treatment were determined to be re-treatment patients older than 46 years of age while in the Nigerian study [15] 44.2% who defaulted treatment were older than 65 years and in India [13] not completing the process of diagnosis of TB was higher in >50 years age.
In our study, there was a limited data on Drug use, alcohol smoking, and HIV as it was not documented in our record. Indeed this is an important omission in the process of care of these patients which should be remedied realizing that there is some linkage between retreatment TB and these social habits. The previous study [16] among miners in South Africa has shown that HIV infection was associated with significantly increased rates of recurrent TB with an incidence of 8.2/100 per year in HIV positive compared to 2.2/100 persons per year in HIV negative men. The need to test patients is recognized in the hospital however, patients can decline after voluntary counseling or confidentiality.
Study Limitations
As a retrospective study, limitation of this study is its retrospective design as the study relies on the previously collected data and some of the information was incomplete, like educational status, employment status, addictions among patients, and other socioeconomic factors of patients which may have an influence on the treatment outcomes were not studied.
